Alpha 2.0
Login Register
» Articles » PMID: 22205138

Imaging Thrombus in Cancer Patients with FDG PET-CT

Overview
Journal Jpn J Radiol
Publisher Springer
Specialty Radiology
Date 2011 Dec 30
PMID 22205138
Citations 6
Authors
Punit Sharma
Rakesh Kumar
Harmandeep Singh
Sunil Jeph
Manish Patnecha
Rama Mohan Reddy
Niraj Naswa
Chandrasekhar Bal
Arun Malhotra
Affiliations
Soon will be listed here.
Abstract

The incidence of thrombosis in patients with underlying primary malignancy is high. The thrombus may be the more common venous thromboembolism (VTE) or the rare tumour thrombus. VTE is a common entity in cancer patients and is managed with anticoagulant therapy, while tumour thrombosis requires aggressive multimodality management. Conventional imaging modalities, including ultrasonography, venography, contrast-enhanced computed tomography, and magnetic resonance imaging, are used routinely in such cases. With its increasing use in oncology, more and more such thrombi are encountered on 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT). Accurate characterisation of these lesions is of utmost importance owing to complementary functional information which it provides. FDG PET-CT has been found to be helpful in this context. This pictorial review discusses and illustrates the imaging features of thrombosis on FDG PET-CT.

Citing Articles

Utility of metabolic ratios in the diagnosis of tumor Thrombus on F-18 FDG PET/CT.

Datta D, Kumar R, Goel A EJNMMI Rep. 2024; 8(1):12.

PMID: 38748073 PMC: 11076428. DOI: 10.1186/s41824-024-00201-z.

Reinventing Molecular Imaging with Total-Body PET, Part II: Clinical Applications.

Saboury B, Morris M, Nikpanah M, Werner T, Jones E, Alavi A PET Clin. 2020; 15(4):463-475.

PMID: 32888545 PMC: 7462547. DOI: 10.1016/j.cpet.2020.06.013.

An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Alavi A, Hess S, Werner T, Hoilund-Carlsen P Eur J Nucl Med Mol Imaging. 2019; 47(1):18-27.

PMID: 31482427 DOI: 10.1007/s00259-019-04490-6.

Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism: New Imaging Tools and Modalities.

Rahaghi F, Minhas J, Heresi G Clin Chest Med. 2018; 39(3):493-504.

PMID: 30122174 PMC: 6317734. DOI: 10.1016/j.ccm.2018.04.003.

Advanced imaging in acute and chronic deep vein thrombosis.

Karande G, Hedgire S, Sanchez Y, Baliyan V, Mishra V, Ganguli S Cardiovasc Diagn Ther. 2017; 6(6):493-507.

PMID: 28123971 PMC: 5220209. DOI: 10.21037/cdt.2016.12.06.

References
1.
Hanajiri K, Mitsui H, Maruyama T, Kondo Y, Shiina S, Omata M . 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus. J Gastroenterol. 2005; 40(10):1005-6. DOI: 10.1007/s00535-005-1667-z. View
2.
Strobel K, Steinert H, Bhure U, Koma A, Gassmann N, Stockli S . Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings. Eur J Nucl Med Mol Imaging. 2007; 34(5):813. DOI: 10.1007/s00259-006-0349-2. View
3.
Carter C . The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis. 1994; 36(6):423-38. DOI: 10.1016/s0033-0620(94)80051-0. View
4.
Plutchok J, Boxt L, Weinberger J, Fawwaz R, Sherman W, van Heertum R . Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging. Clin Nucl Med. 1998; 23(5):324-5. DOI: 10.1097/00003072-199805000-00014. View
5.
Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K . FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001; 42(10):1551-5. View